Nanobiotix’s Post

HORIZON-EIC-2022-TRANSITIONOPEN-01–EIC Transition Open 2022 Grant agreement n.100113193 https://lnkd.in/eV_KUvbE Unsolved needs. Health programs crave for diagnostic imaging and eradication of chemoresistant neoplastic lesions smaller than 1 mm of size. PHIRE aims at bringing closer to market a novel high-resolution theranostic medical device effective in the clinical applications for lesions <1 mm, ready for application in human bladder cancer and effective both in male and female patients. PHIRE aims. The adoption of PHIRE solution in relevant environment, by providing: - an add-on module for pre-existing off-the shelf photoacoustic device allowing to perform photoacoustic imaging of hollow organs located deeper in human body, designed to be used in combination with - an artificial intelligence-assisted prediction map for the image-guided gold nanorods assisted photo-thermal therapy, - a large-scale synthesis of urine-stable gold nanorods for clinical use.   The adoption for clinical applications of this new device will reduce the frequency of the bladder tumor relapse and the number of patients with relapsing tumor, with a drastic positive impact on the quality of life of patients while reducing the social cost of the management of patients. Furthermore, PHIRE’s outcomes will open up the way for the deployment of theranostic application against lesions <1 mm in other hollow human organs. PHIRE innovative solutions will also be applicable to other markets, such as that of photoacoustic and diagnostic imaging, gold nanoparticles, cystoscopy and medical software.

In the realm of #neurology, the journey from research to treatment is complex. BioPharma Services Inc. is your first step of turning neuroscientific discoveries into effective therapies. Neurological disorders, affecting millions, require innovative approaches. As a specialized Canadian CRO, we focus on: 🧠 Innovative Trial Designs: Custom studies for neurological disorders, using adaptive designs and biomarkers. 🧠 Advanced Analytics: Employing AI for deeper insights, improving outcomes. 🧠 Patient-Centric Models: Prioritizing patient engagement in trials, ensuring accessibility and friendliness. Connect with us to explore how we can transform neurology research into real-world solutions. Want to learn more? Click here to get started 👇 https://hubs.li/Q02qKnyN0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #genericdrugs #biotech #pharmaceuticalindustry

Did you know we have over 100 peer-reviewed publications featured on our website from our customers and scientists? From modeling complex human diseases to advancing drug discovery and toxicology studies, our 3D human tissue models, developed using the OrganoPlate® platform, are paving the way for breakthrough therapies.    🔍 Looking for research on specific organ models? You can now filter through our publications based on 15 different organ and disease models, including cancer, brain, liver, intestine, and more. Explore our publications here: https://lnkd.in/e9v3K7J9 #OrganModels #OrganOnAChip #Publications  #ScienceandTechnology

Interested in learning more regarding what all the hype is about surrounding AI ablation and advanced technologies? 🤖 🌟Then join the webinar below!CASCINATION #aitechnolgy #qualtiyablation #medtech

Hemanext is transforming blood storage with the Hemanext ONE Red Blood Cell (#RBC) Processing and Storage system, designed to bring new levels of innovation, clinical value and consistency to #transfusion medicine. Watch Hemanext’s demo video: https://lnkd.in/dMFg-cnn #hemanext #hemanextONE

Pre-holiday thought 𝐂𝐨𝐫𝐫𝐮𝐩𝐭𝐢𝐬𝐬𝐢𝐦𝐚 𝐫𝐞 𝐩𝐮𝐛𝐥𝐢𝐜𝐚 𝐩𝐥𝐮𝐫𝐢𝐦𝐚𝐞 𝐥𝐞𝐠𝐞𝐬 - #Tacito ( 1st century AD ) #MedicalDevicesRegulations https://lnkd.in/d2kMkMuU Guidance - MDCG endorsed documents and other guidance https://lnkd.in/dcscNrrD AI Act https://lnkd.in/dD-kKggk The ‘Blue Guide’ on the implementation of EU products rules 2016 (Text with EEA relevance) https://lnkd.in/dQZQ5_Sn Complete guide to GDPR compliance https://lnkd.in/dQZQ5_Sn Without considering: state of the art, harmonized standards, non-harmonized standards, guidelines, EU Pharmacopoeia etc etc etc

This is a nice, quick-read interview. The cell and gene therapy challenges mentioned are spot on: 1. Cryopreservation Best Practices 2. Biostorage SOPs + Training 3. Intra-campus therapy transport at the point of care And my addition: 4. The therapy thawing process Thankfully there are existing and new solutions in the market that can help de-risk. #celltherapy #genetherapy #CGT #cryopreservation

AI can greatly enhance the efficiency of clinical research studies by automating data analysis, patient monitoring, and report generation. "However, the use of AI also presents risks, particularly concerning the protection of sensitive patient information". Balancing innovation with privacy protection is key to advancing clinical research safely. 🔐 🧠🧪📊 https://lnkd.in/eg5-_7P6

𝐀𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $3.9 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 Download PDF Brochure@ https://lnkd.in/dFASMmru The report "𝐀𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 (𝐃𝐞𝐯𝐢𝐜𝐞 (𝐂𝐞𝐧𝐭𝐫𝐢𝐟𝐮𝐠𝐚𝐭𝐢𝐨𝐧, 𝐌𝐞𝐦𝐛𝐫𝐚𝐧𝐞 𝐒𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧) 𝐃𝐢𝐬𝐩𝐨𝐬𝐚𝐛𝐥𝐞), 𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞 (𝐃𝐨𝐧𝐨𝐫, 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜), 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 (𝐏𝐥𝐚𝐬𝐦𝐚𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬, 𝐏𝐥𝐚𝐭𝐞𝐥𝐞𝐭𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬), 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲, 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥, 𝐁𝐥𝐨𝐨𝐝 𝐂𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐂𝐞𝐧𝐭𝐞𝐫), 𝐑𝐞𝐠𝐢𝐨𝐧 - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2029", is valued at an estimated 2.6 billion in 2024 and is projected to reach USD 3.9 billion by 2029, at a CAGR of 8.8% during the forecast period. --> Companies Profiled in This Report: Terumo Blood and Cell Technologies Fresenius SE & Co. KGaA Haemonetics Baxter International Inc. Asahi Kasei MEDICA S.p.A. Mallinckrodt Pharmaceuticals BD OT Bioelettronica Infomed CytoSorbents Corporation medicap clinic GmbH Haier Biomedical International B. Braun Group Cerus Kaneka North America SB-Kawasumi Laboratories, Inc Nikkiso Co Ltd Macopharma Miltenyi Biotec Otsuka Holdings Co., Ltd. Puriblood Lmb Technologie GmbH Beijing ZKSK Technology Guangzhou Daji Medical Science and Technology Co., Ltd --> Other Companies Operating in This Industry, Globally: PlasmaGenix, Inc. HemaCare Corporation, a Charles River Company ImmunoTek Bio Centers, LLC VitaCyte BioPure Technology Ltd Cellexus NanoBlood LLC Plasma Quest Ltd AstraPharma GmbH CellWave Technologies BIOMEDITECH #PlasmaApheresis, #ApheresisTechnology, #BloodCollection, #PlasmaCollection, #CellSeparation, #BloodDonor, #MedicalApheresis, #ApheresisEquipment, #ApheresisTreatment, #Hematology, #BloodTherapy, #PlasmaTherapy, #CellTherapy, #HematologyTechnology, #ApheresisDevices, #BloodComponents, #MedicalDevices, #HealthcareInnovation, #BloodManagement, #PlasmaProcessing, #BloodDonation, #MedicalTechnology, #BloodTransfusion, #ApheresisCenter, #BloodSolutions, #PlasmaSolutions, #CellSeparationTechnology, #ApheresisSystem, #PlasmaExchange, #BloodCare, #ApheresisInMedicine, #AdvancedApheresis, #BloodHealth, #PlasmaHealth, #CellHealth, #BloodComponentSeparation, and #InnovativeApheresis

New artificial intelligence-powered software said to improve the detection of small lesions on brain MR imaging was just granted clearance by the U.S. Food and Drug Administration. https://loom.ly/2llIKuA